Drug Discovery Outsourcing Market is a rapidly growing trend in the pharmaceutical industry, allowing companies to access a broader range of expertise and resources while reducing costs and risks. North America is one of the largest markets for drug discovery outsourcing due to the presence of several leading pharmaceutical companies and research institutions. Outsourcing drug discovery activities to specialized service providers in North America can provide several benefits, including access to cutting-edge technologies and expertise, faster turnaround times, and reduced capital expenditures. Furthermore, outsourcing enables companies to focus on their core competencies while outsourcing non-core activities to specialized service providers. North America has a robust regulatory framework and a highly skilled workforce, making it an attractive destination for outsourcing drug discovery activities. Service providers in North America offer a range of drug discovery services, including target identification and validation, lead optimization, and preclinical development. The increasing demand for drug discovery outsourcing services in North America is expected to drive market growth in the coming years.

Access For Sample PDF- https://univdatos.com/report/drug-discovery-outsourcing-market/get-a-free-sample-form.php?product_id=38238

Further, the North America Drug discovery outsourcing market was valued at USD 3 billion in 2021 & is expected to grow at a CAGR of 7% from 2022-2030. This is mainly due to the emergence of new technologies such as genomics, proteomics, and bioinformatics driving the need for specialized expertise, which can be accessed through outsourcing.

 FIG. 1      North America Drug Discovery Outsourcing Market Revenue (2020-2030)- USD Mn

Based on drug type, the market is segmented into small molecule and large molecules (biopharmaceuticals). Amongst these, the small molecule category dominated the market in 2021. This is mainly due to the rapid advancement of biopharmaceutical research & technology for the discovery and some distinct advantages, such as it can be administered orally and can pass through membranes to reach intracellular targets more precisely as compared to large molecules.

By therapeutic area, the market is bifurcated into oncology, infectious disease, respiratory disease, cardiovascular, gastrointestinal, and others. Among these, the respiratory disease category captured the majority share of the drug discovery outsourcing market in 2021. This is mainly due to the rising number of cases of drug resistance and the high prevalence of respiratory diseases like bronchitis, tuberculosis, COPD, and asthma. For instance, in 2019, according to (AAFA), Asthma and Allergy Foundation of America, nearly 26 million people in the U.S. were diagnosed with asthma.

Global Drug Discovery Outsourcing Market Segmentation

Market Insight, by Type

·        Medical Chemistry Service

·        Biology Service

Market Insights, by Drug Type

·        Small Molecule

·        Large Molecules (Biopharmaceuticals)

Market Insights, by Therapeutic Area

·        Oncology

·        Infectious Disease

·        Respiratory Disease

·        Cardiovascular

·        Gastrointestinal

·        Others

Market Insight, by Region

·        North America

o   U.S.

o   Canada

o   Rest of North America

·        Europe

o  Germany

o  UK

o  France

o  Italy

o  Spain

o  Rest of Europe

·        APAC

o  China

o  India

o  Japan

o  Rest of APAC

·        Rest of the World

Top Company Profiles

·        Curia Global, Inc.

·        Evotec

·        Laboratory Corporation of America® Holdings

·        Genscript

·        Thermo Fisher Scientific Inc.

·        Charles River Laboratories

·        WuXi AppTec

·        Merck & Co., Inc.

·        Qiagen

·        Jubilant Biosys Ltd.

·        Eurofins DiscoverX Product